March 27, 2025

There is an ongoing legal and regulatory battle between pharmaceutical companies and compounding pharmacies over the production of copycat versions of popular weight-loss drugs. The perspectives of drugmakers, telehealth platforms, and policymakers are highlighted as the FDA moves to enforce restrictions on compounded medications.

The Trump administration has proposed changes to the Affordable Care Act aimed at reducing fraudulent enrollments by adding stricter verification requirements and shortening the enrollment period by a month. The proposed rule would also remove eligibility for certain individuals.

On Tuesday, the Senate Finance Committee voted 14-13 along party lines to advance Dr. Oz’s nomination to a full Senate vote. Dr. Oz has publicly supported Medicaid work requirements, which would mandate recipients to document work, volunteer, or educational activities to maintain their benefits. His stance has drawn sharp criticism from opponents who argue it could lead to coverage losses for vulnerable populations.

A survey of over a thousand physicians found that while burnout remains a significant issue post-pandemic, both burnout rates and physicians' intentions to leave their jobs declined in 2025 compared to 2024. Despite ongoing concerns about AI diminishing the human touch in healthcare, many physicians report that AI-driven tools—particularly for documentation and transcription—are easing administrative burdens and improving workflow efficiency.

The rapid rise in GLP-1 spending presents a growing challenge for payers, who must balance access to these high-demand therapies with the need to manage escalating healthcare costs.